ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RPHM Reneo Pharmaceuticals Inc

18.20
0.00 (0.00%)
13 Mar 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Reneo Pharmaceuticals Inc NASDAQ:RPHM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.20 1.75 1.88 0 00:00:00

Form 3 - Initial statement of beneficial ownership of securities

09/10/2024 12:07am

Edgar (US Regulatory)


LIMITED POWER OF ATTORNEY - SECURITIES LAW COMPLIANCE

The undersigned, as an officer or director of OnKure Therapeutics, Inc. (the Corporation),

hereby constitutes and appoints Jason Leverone and Rogan Nunn, each the undersigneds true and

lawful attorney-in-fact and agent to complete and execute such Forms 144, Form ID, Forms 3, 4

and5 and other forms as such attorney shall in his or her discretion determine to be required or

advisable pursuant to Rule 144 promulgated under the Securities Act of 1933, as amended, Section

16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated

thereunder, or any successor laws and regulations, as a consequence of the undersigneds ownership,

acquisition or disposition of securities of the Corporation, and to do all acts necessary in order to file

such forms with the Securities and Exchange Commission, any securities exchange or national

association, the Corporation and such other person or agency as the attorney shall deem appropriate.

The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall do or

cause to be done by virtue hereof.  The undersigned acknowledges that the foregoing attorneys-in

fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the

Corporation assuming, any of the undersigned's responsibilities to comply with Section 16 of the

Securities Exchange Act of 1934, as amended.

This Limited Power of Attorney shall remain in full force and effect until the undersigned is no

longer required to file Form 144, and/or Forms 3, 4 and 5 with respect to the undersigned's holdings

of and transactions in securities issued by the Corporation unless earlier revoked by the undersigned

in a writing delivered to the foregoing attorneys-in-fact.

This Limited Power of Attorney is executed as of the date set forth below.



Signature:  /s/ R. Michael Carruthers


Print Name:  R. Michael Carruthers

Dated:  September 18, 2024









-0-

C:NRPortblpalib2JBM9420504_1.docx (1622)


1 Year Reneo Pharmaceuticals Chart

1 Year Reneo Pharmaceuticals Chart

1 Month Reneo Pharmaceuticals Chart

1 Month Reneo Pharmaceuticals Chart